arch43
EN_01462003_0896
-- IMAGE RESTRICTED TO EDITORIAL USE - STRICTLY NO COMMERCIAL USE --
(FILES) This file picture taken on November 18, 2020 shows a syringe and a bottle reading "Vaccine Covid-19" next to the Moderna biotech company logo. - US biotechnology firm Moderna on January 25, 2021 said lab studies showed its Covid-19 vaccine would remain protective against variants of the coronavirus first identified in the United Kingdom and South Africa. "The study showed no significant impact" on the level of neutralizing antibodies elicited against the UK variant, B.1.1.7. (Photo by JOEL SAGET / AFP) / -- IMAGE RESTRICTED TO EDITORIAL USE - STRICTLY NO COMMERCIAL USE --
2020-11-18
JOEL SAGET/AFP/East News
AFP
JOEL SAGET
AFP_8ZH6GU
2,24MB
46cm x 31cm by 300dpi
-, 1, 18, 2020, 2021, 25, 7, A, AFRICA, AGAINST, AND, ANTIBODIES, BIOTECH, BIOTECHNOLOGY, BOTTLE, BY, COMMERCIAL, COMPANY, CORONAVIRUS, COVID-19, EDITORIAL, ELICITED, FILE, FILES, FIRM, FIRST, HEALTH, HORIZONTAL, IDENTIFIED, ILLUSTRATION, IMAGE, IMPACT, IN, INDUSTRY, ITS, JANUARY, JOEL, KINGDOM, LAB, LEVEL, LOGO, MEDICINE, MODERNA, NEUTRALIZING, NEXT, NO, NOVEMBER, OF, ON, PHARMACEUTICAL, PICTURE, PROTECTIVE, READING, REMAIN, RESTRICTED, SAGET, SAID, SHOWED, SHOWS, SIGNIFICANT, SOUTH, STRICTLY, STUDIES, STUDY, SYRINGE, TAKEN, THE, THIS, TO, UK, UNITED, US, USE, VACCINE, VARIANT, VARIANTS, WOULD,